Bivalirudin and DES: a PCI strategy that pays. [electronic resource]
Producer: 20070227Description: 69-70 p. digitalISSN:- 1557-2501
- Anticoagulants -- adverse effects
- Coronary Artery Disease -- therapy
- Costs and Cost Analysis
- Drug Delivery Systems
- Heparin -- adverse effects
- Hirudins -- adverse effects
- Humans
- Immunosuppressive Agents -- administration & dosage
- Length of Stay -- economics
- Myocardial Infarction -- drug therapy
- Paclitaxel -- administration & dosage
- Peptide Fragments -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Recombinant Proteins -- adverse effects
- Sirolimus -- administration & dosage
- Stents -- economics
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.